- Paper Report
- Open Access
Deficiency of Il-1ra may predispose to development of arthritis
- Oliver Fitzgerald1
© Current Science Ltd 2000
- Published: 10 April 2000
- IL-1ra gene deficiency
- mouse model
- rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic systemic disease which commonly results in joint damage and consequent disability. Various pro-inflammatory cytokines such as IL-1, IL-6 and tumor necrosis factor (TNF)-a are overexpressed in the joints of RA patients. IL-1 is thought to be a major mediator of inflammation as it exerts a number of biological activities by binding the IL-1 type I receptor. IL-1ra is a naturally occurring inhibitor of IL-1 which competes for the receptor. Previous studies have suggested that IL-1ra production may be relatively deficient or inadequate in RA patients. IL-1ra gene polymorphism has not, as yet, been reported in RA in humans. To study the pathophysiological roles of IL-1ra in regulating the inflammatory response.
IL-1ra-deficient mice on a BALB/cA background all developed a chronic inflammatory arthropathy by 16 weeks. In contrast, none of the IL-1ra-deficient mice on a C57BL/6J background developed any arthritis at 16 weeks of age. In mice developing arthritis, both the incidence and severity gradually increased to a maximum at 16 weeks. Marked synovial and periarticular inflammation was observed with articular erosion resulting from invasion of granulation tissue. These findings are similar to those of RA in humans. T-cell and B-cell composition in lymphoid tissue was not altered by IL-1ra deficiency. Total IgG and IgE levels were elevated two- to threefold at 16 weeks in mice with arthritis. In addition, there was a significant elevation in antibody levels against IgG, type II collagen and double-stranded DNA. Finally, the IL-1? mRNA level was increased tenfold in arthritic joints at 16 weeks compared to that for controls and expression levels of IL-6, TNF-a and COX-2 were also augmented. Interestingly, the augmentation of these genes was observed in joints before the onset of clinical disease.
IL-1ra-deficient mice were produced by gene targeting. The mice were then backcrossed to several lines of inbred mice of different genetic backgrounds to see the difference in inflammatory reactions amongst strains. The histological features, autoantibody production and synovial cytokine expression were determined.